273 related articles for article (PubMed ID: 8166746)
1. Kinetic analysis of novel inhibitors of inositol polyphosphate metabolism.
Hansbro PM; Foster PS; Liu C; Potter BV; Denborough MA
Biochem Biophys Res Commun; 1994 Apr; 200(1):8-15. PubMed ID: 8166746
[TBL] [Abstract][Full Text] [Related]
2. Design of potent and selective inhibitors of myo-inositol 1,4,5-trisphosphate 5-phosphatase.
Safrany ST; Mills SJ; Liu C; Lampe D; Noble NJ; Nahorski SR; Potter BV
Biochemistry; 1994 Sep; 33(35):10763-9. PubMed ID: 8075077
[TBL] [Abstract][Full Text] [Related]
3. Calcium release activity and metabolism of inositol 1,4,5-trisphosphate in T cells. Modulation by novel inositol 1,4,5-trisphosphate 5-phosphatase inhibitors.
Ward SG; Lampe D; Liu C; Potter BV; Westwick J
Eur J Biochem; 1994 Jun; 222(2):515-23. PubMed ID: 8020489
[TBL] [Abstract][Full Text] [Related]
4. The metabolism of D-myo-inositol 1,4,5-trisphosphate and D-myo-inositol 1,3,4,5-tetrakisphosphate by porcine skeletal muscle.
Foster PS; Hogan SP; Hansbro PM; O'Brien R; Potter BV; Ozaki S; Denborough MA
Eur J Biochem; 1994 Jun; 222(3):955-64. PubMed ID: 8026506
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of inositol 1,4,5-trisphosphate analogues by 3-kinase and dephosphorylation of inositol 1,3,4,5-tetrakisphosphate analogues by 5-phosphatase.
Van Dijken P; Lammers AA; Ozaki S; Potter BV; Erneux C; Van Haastert PJ
Eur J Biochem; 1994 Dec; 226(2):561-6. PubMed ID: 8001571
[TBL] [Abstract][Full Text] [Related]
6. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
Safrany ST; Wilcox RA; Liu C; Dubreuil D; Potter BV; Nahorski SR
Mol Pharmacol; 1993 Apr; 43(4):499-503. PubMed ID: 8386304
[TBL] [Abstract][Full Text] [Related]
7. Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities.
Wilcox RA; Safrany ST; Lampe D; Mills SJ; Nahorski SR; Potter BV
Eur J Biochem; 1994 Jul; 223(1):115-24. PubMed ID: 8033885
[TBL] [Abstract][Full Text] [Related]
8. Inositol 1,3,4,5,6-pentakisphosphate and inositol hexakisphosphate are inhibitors of the soluble inositol 1,3,4,5-tetrakisphosphate 3-phosphatase and the inositol 1,4,5-trisphosphate/1,3,4,5-tetrakisphosphate 5-phosphatase from pig brain.
Höer A; Oberdisse E
Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):219-24. PubMed ID: 1652939
[TBL] [Abstract][Full Text] [Related]
9. Ca2(+)-mobilising properties of synthetic fluoro-analogues of myo-inositol 1,4,5-trisphosphate and their interaction with myo-inositol 1,4,5-trisphosphate 3-kinase and 5-phosphatase.
Safrany ST; Sawyer D; Wojcikiewicz RJ; Nahorski SR; Potter BV
FEBS Lett; 1990 Dec; 276(1-2):91-4. PubMed ID: 2176165
[TBL] [Abstract][Full Text] [Related]
10. Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
Safrany ST; Wojcikiewicz RJ; Strupish J; McBain J; Cooke AM; Potter BV; Nahorski SR
Mol Pharmacol; 1991 Jun; 39(6):754-61. PubMed ID: 1646949
[TBL] [Abstract][Full Text] [Related]
11. D-myo-inositol 1,4,5-trisphosphate analogues modified at the 3-position inhibit phosphatidylinositol 3-kinase.
Ward SG; Mills SJ; Liu C; Westwick J; Potter BV
J Biol Chem; 1995 May; 270(20):12075-84. PubMed ID: 7744856
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of D-myo-inositol 1,3,4,5-tetrakisphosphate by rat liver, including the synthesis of a novel isomer of myo-inositol tetrakisphosphate.
Shears SB; Parry JB; Tang EK; Irvine RF; Michell RH; Kirk CJ
Biochem J; 1987 Aug; 246(1):139-47. PubMed ID: 2823793
[TBL] [Abstract][Full Text] [Related]
13. Purification and characterization of D-myo-inositol (1,4,5)/(1,3,4,5)- polyphosphate 5-phosphatase from skeletal muscle.
Hansbro PM; Foster PS; Hogan SP; Ozaki S; Denborough MA
Arch Biochem Biophys; 1994 May; 311(1):47-54. PubMed ID: 8185320
[TBL] [Abstract][Full Text] [Related]
14. Roles for hydroxyl groups of D-myo-inositol 1,4,5-trisphosphate in the recognition by its receptor and metabolic enzymes.
Hirata M; Watanabe Y; Yoshida M; Koga T; Ozaki S
J Biol Chem; 1993 Sep; 268(26):19260-6. PubMed ID: 8396130
[TBL] [Abstract][Full Text] [Related]
15. Inositol-1,3,4,5-tetrakisphosphate induces calcium mobilization via the inositol-1,4,5-trisphosphate receptor in SH-SY5Y neuroblastoma cells.
Wilcox RA; Challiss RA; Liu C; Potter BV; Nahorski SR
Mol Pharmacol; 1993 Oct; 44(4):810-7. PubMed ID: 8232232
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of inositol 1,4,5-trisphosphate metabolism in permeabilised SH-SY5Y human neuroblastoma cells by a phosphorothioate-containing analogue of inositol 1,4,5-trisphosphate.
Wojcikiewicz RJ; Cooke AM; Potter BV; Nahorski SR
Eur J Biochem; 1990 Sep; 192(2):459-67. PubMed ID: 2209601
[TBL] [Abstract][Full Text] [Related]
17. myo-inositol 1,4,5-trisphosphorothioate is a potent competitive inhibitor of human erythrocyte 5-phosphatase.
Cooke AM; Nahorski SR; Potter BV
FEBS Lett; 1989 Jan; 242(2):373-7. PubMed ID: 2536622
[TBL] [Abstract][Full Text] [Related]
18. The dephosphorylation pathway of D-myo-inositol 1,3,4,5-tetrakisphosphate in rat brain.
Erneux C; Delvaux A; Moreau C; Dumont JE
Biochem J; 1987 Nov; 247(3):635-9. PubMed ID: 2827634
[TBL] [Abstract][Full Text] [Related]
19. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
Hirata M; Narumoto N; Watanabe Y; Kanematsu T; Koga T; Ozaki S
Mol Pharmacol; 1994 Feb; 45(2):271-6. PubMed ID: 8114676
[TBL] [Abstract][Full Text] [Related]
20. Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase.
Safrany ST; Wojcikiewicz RJ; Strupish J; Nahorski SR; Dubreuil D; Cleophax J; Gero SD; Potter BV
FEBS Lett; 1991 Jan; 278(2):252-6. PubMed ID: 1846823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
